Botox gains FDA approval for axillary hyperhidrosis; off-label use has been fairly common.(Food and Drug Administration)(botulinum toxin type A): An article from: Skin & Allergy News by International Medical News Group

Title: Botox gains FDA approval for axillary hyperhidrosis; off-label use has been fairly common.(Food and Drug Administration)(botulinum toxin type A): An article from: Skin & Allergy News

Manufacturer: International Medical News Group
List Price: $5.95
Our Price: $5.95